• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 4, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Lloyd Paul Aiello receives JDRF Award for Excellence in Type 1…

Bioengineer.org by Bioengineer.org
January 18, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: John Soares

Boston – (June 12, 2017) – The JDRF has awarded Lloyd Paul Aiello, M.D., Ph.D., the 2017 JDRF Mary Tyler Moore and S. Robert Levine Excellence in Clinical Research Award. The announcement was made during the JDRF One Conference in Chicago, Ill.

Dr. Aiello is Director of the Beetham Eye Institute at Joslin Diabetes Center, and Professor of Ophthalmology and Vice Chair of the Department of Ophthalmology at Harvard Medical School.

This award is named in honor of JDRF chairman, the late Mary Tyler Moore, who had type 1 diabetes for over 40 years, and her husband, S. Robert Levine, M.D. It is given to recognize outstanding clinical and translational type 1 diabetes research.

Dr. Lloyd Paul Aiello was the inaugural chair of the Diabetic Retinopathy Clinical Research Network and focuses his clinical and research interests on eliminating vision loss due to diabetic retinopathy and other related retinopathies.

His research aims to determine the underlying biochemistry and molecular mechanisms of these diseases, then develop and test novel therapeutic interventions through rigorous translational and clinical trial research.

The pioneering work of Dr. Aiello helped demonstrate the role of vascular endothelial growth factor (VEGF) in diabetic retinopathy and other retinal disorders, as well as the therapeutic potential of VEGF inhibitors in these conditions. Along with colleagues George L. King, M.D., and Edward P. Feener, Ph.D., at the Joslin Diabetes Center, Dr. Aiello also contributed to the first evidence that protein kinase C-beta (PKC-beta) and plasma kallikrein are involved in vascular leakage in diabetic retinopathy.

Dr. Aiello is recognized internationally for his leadership in diabetic retinopathy research. In 2002, he helped found and then served as the inaugural chair of the Diabetic Retinopathy Clinical Research Network (DRCR.net), a national collaborative network dedicated to facilitating multicenter clinical research for diabetic retinopathy, diabetic macular edema, and related disorders. Funded by the National Eye Institute, DRCR.net now includes over 150 centers nationwide representing academic medical institutions and private practice groups.

During his career, Dr. Aiello has received numerous awards, including sharing the 2014 Antonio Champalimaud Vision Award with Dr. George L. King at Joslin for their contributions toward the discovery of treatments inhibiting vascular endothelial growth factor (VEGF) for diabetic eye disease.

Dr. Aiello received his doctoral degree in Biochemistry and a medical degree from Boston University School of Medicine. He completed residency in ophthalmology at the Wilmer Ophthalmological Institute at Johns Hopkins University and Hospital before coming to the Joslin Diabetes Center, where he completed both a clinical vitreoretinal, and a research fellowship. He joined the Joslin staff in 1994.

"Dr. Aiello has impacted millions of patients' lives by preserving their vision as a result of discoveries he and his colleagues have made through their pioneering work at Joslin," said Peter S. Amenta, M.D., Ph.D., President and C.E.O. of Joslin Diabetes Center. "He has changed the course of the care and prevention of diabetes-related eye disease, and the 2017 JDRF Mary Tyler Moore and S. Robert Levine Excellence in Clinical Research Award is a fitting way to honor his contributions."

###

About Joslin Diabetes Center

Joslin Diabetes Center is world-renowned for its deep expertise in diabetes treatment and research. Joslin is dedicated to finding a cure for diabetes and ensuring that people with diabetes live long, healthy lives. We develop and disseminate innovative patient therapies and scientific discoveries throughout the world. Joslin is an independent, non-profit institution affiliated with Harvard Medical School, and one of only 11 NIH-designated Diabetes Research Centers in the U.S.

For more information, visit http://www.joslin.org or follow @joslindiabetes

Media Contact

Jeffrey Bright
[email protected]
@joslindiabetes

http://www.joslin.org

Original Source

http://www.joslin.org/news/Lloyd-Paul-Aiello-MD-PhD-receives-2017-JDRF-Mary-Tyler-Moore-award-for-clinical-research.html

Share12Tweet7Share2ShareShareShare1

Related Posts

Integrating Universal Screening and School-Based Mental Health Initiatives into Classroom Settings

November 4, 2025

Unraveling How Sugars Influence the Inflammatory Disease Process

November 4, 2025

Integrating Medical Student Mentors in Engineering Teams

November 4, 2025

Controlling Urination via Spinal EUS Nerve Stimulation

November 4, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1298 shares
    Share 518 Tweet 324
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    313 shares
    Share 125 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    205 shares
    Share 82 Tweet 51
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    138 shares
    Share 55 Tweet 35

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Revolutionary Knitting Machine Constructs Solid 3D Objects

Integrating Universal Screening and School-Based Mental Health Initiatives into Classroom Settings

Unraveling How Sugars Influence the Inflammatory Disease Process

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.